General Electric Company

Sabic Innovative Plastics IP B.v.

General Electric Corporation Gmbh

Sabic Global Technolgoies B.v.

Ge Healthcare Limited

Robert Edgar Colborn

Peter John Bonitatibus, Jr

Andrew Soliz Torres

Matthew David Butts

James R Presley

Dan Hancu

David Bruce Hall

Michael John Davis

Peter Koch

Gary William Yeager

Amit Mohan Kulkarni

Patricia Chapman Irwin

John E Hallgren

Donald A Bolon

John H Lupinski

Bruce Allan Hay

Mark Markovitz

Daniel Steiger

Michael G Minnick

Brian Christopher Bales

Stanley Young Hobbs

Victoria J Eddy

Erik W Walles

Ali Ersin Acar

Steven J Kubisen, Jr

Fazila Seker

Gerald Oeckel

Richard Joseph Kilmer

Larry Neil Lewis

Deborah Ann Haitko

Herbert S Chao

Francis Johnson

Binil Itty Ipe Kandapallil

Thomas Wessel

Prashant Anil Tatake

James E Tracy

Michael Ernest Marino

Eelco M S Van Hamersveld

John E Pace

Jana M Whalen

Chris Hartshorn

Edward F Chu

Bernd Volker Demuth

Shyamal Bhaskar Gondkar

Kwang Woong Won

Robert Russell Gallucci

Paul Dean Sybert

Patrick Joseph McCloskey

Gary Charles Davis

Roy Ray Odle

Eugene Pauling Boden

Kwok Pong Chan

Jimmy Lynn Webb

Brian Daniel Mullen

Farid Fouad Khouri

John Patrick Lemmon

Arunkumar Natarajan

Joseph A King, Jr

Paul William Buckley

Oskar Axelsson

Pradeep Jeevaji Nadkarni

Kathryn Lynn Longley

Judson Sloan Marte

John Morgan Whitney

Albert Santo Stella

Paul Edward Howson

Irene Dris

Marsha Mottel Grade

Tara Jane Mullen

Evgenia Mikhailovna Kim

Balakrishnan Ganesan

Glen David Merfeld

Ashish Balkrishna Mhadeshwar

Vern Lowry

Matthew Hal Littlejohn

Shripathy Vilasagar

Karl E Mack

John Matthew Bablin

Utpal Mahendra Vakil

Bryan Duffey

Jianbo Di

Constantin Donea

Moitreyee Sinha

Ke Feng

Christina Chen

Eelco Michiel Sebastiaan Van Hamersveld

David Cheney deMoulpied

David Francis Townsend

Philip L Angermeier

Laura G Schultz

Mohammed Haouaoui

Christopher Mark Hartshorn

Dane M Ferraris

Michacl Ernest Marino

Katherine Lee Jackson

Uptal Mahendra Vakil

KarlErnst Mack

Peter John Bonitatibus Jr

Compositions of nanoparticles functionalized with at least one zwitterionic moiety, methods for making a plurality of nanoparticles, and methods of their use as diagnostic agents are provided. The nanoparticles have characteristics that result in minimal retention of the particles in the body compared to other nanoparticles. The nanoparticle comprising a nanoparticulate transition metal oxide covalently functionalized with a silane-functionalized non-targeting zwitterionic moiety.

Nanoparticle contrast agents for diagnostic imaging

A method of making a nanocomposite permanent magnet is provided. The method comprises applying an extreme shear deformation to hard magnetic phase nanoparticles and soft magnetic phase nanoparticles to align at least a portion of the hard phase magnetic particles and to produce a nanocomposite permanent magnet.

Nanocomposite permanent magnets and methods of making the same

A method of synthesizing magnetic nanoparticles comprising soft magnetic phases is provided, wherein the method comprises degassing a first mixture at a temperature in a range from about 80&#xb0; C. to 130&#xb0; C. The first mixture comprises a solvent, a compound comprising iron, cobalt, or combinations thereof dissolved in the solvent, and an organic component comprising a fatty acid or an amine. Degassing the first mixture is followed by adding a capping ligand to the first mixture under inert atmosphere to form a second mixture; adding a reducing agent to the second mixture at a temperature in a processing temperature range from about 250&#xb0; C. to about 350&#xb0; C. to form a third mixture; and incubating the third mixture at a temperature within the processing temperature range to form nanoparticles comprising a soft magnetic phase.

Soft magnetic phase nanoparticles preparations and associated methods thereof

The present invention is generally directed to core/shell nanoparticles, wherein such core/shell nanoparticles comprise a nanoparticle core and a nanoshell disposed about the nanoparticle core such that, in the aggregate, they form a core/shell nanoparticle that is operable for use as an imaging agent in X-ray/computed tomography (CT). Typically, such core/shell nanoparticle-based X-ray CT imaging agents further comprise a targeting species for targeting the imaging agent to diseased sites. Included herein are methods for forming such agents, comprising forming an ensemble of core/shell nanoparticles, wherein the mean diameter of the ensemble of core/shell nanoparticles is selected so as to render the nanoparticles in the ensemble substantially clearable by a mammalian kidney.

Nanoparticle-based imaging agents for X-ray/computed tomography and methods for making same

The present invention provides a trialkoxysilane having structure I wherein Ris independently at each occurrence a C-Calkyl group; Ris independently at each occurrence a hydrogen or a C-Calkyl group; Ris a C-Caliphatic radical, a C-Caromatic radical, or a C-Ccycloaliphatic group; n is 0, 1, 2 or 3; q is 1, 2 or 3; t is 0, 1 or 2; and Xrepresents a charge balancing counterion. The trialkoxysilanes are useful for the preparation of nanoparticulate diagnostic imaging agent compositions.

Nanoparticulate compositions for diagnostic imaging

Compositions of nanoparticles functionalized with at least one zwitterionic moiety, methods for making a plurality of nanoparticles, and methods of their use as diagnostic agents are provided. The nanoparticles have characteristics that result in minimal retention of the particles in the body compared to other nanoparticles. The nanoparticle comprises a core, having a core surface essentially free of silica, and a shell attached to the core surface. The shell comprises at least one silane-functionalized zwitterionic moiety.

The present invention provides a trialkoxysilanes having structure I wherein Rand Rare independently at each occurrence a C-Calkyl group; Ris independently at each occurrence a hydrogen or a C-Calkyl group; Ris a C-Caliphatic radical, a C-Caromatic radical, or a C-Ccycloaliphatic group; n is 0, 1, 2 or 3; q is 1, 2 or 3; and Xrepresents a charge balancing counterion. The trialkoxysilanes are useful for the preparation of nanoparticulate diagnostic imaging agent compositions.

According to various embodiments, a catalyst composition includes a catalytic metal secured to a porous substrate. The substrate has pores that are templated. The substrate is a product of adding a substrate precursor to a water-in-oil microemulsion including a catalytic metal salt, a solvent, a templating agent, and water.

Catalyst and method of manufacture

The invention relates generally to optical data storage media, and more specifically, to holographic storage media. In one embodiment, an optical storage medium composition includes a polymer matrix. Disposed within the polymer matrix is a reactant capable of undergoing a modification that alters the refractive index of the composition upon receiving an energy transfer from an excited sensitizer. A non-linear sensitizer is also disposed within the polymer matrix, and the sensitizer includes a metal-substituted subphthalocyanine (M-sub-PC) reverse saturable absorber configured to become excited upon exposure to light beyond an intensity threshold at approximately 405 nm and configured to transfer energy to the reactant.

Reverse saturable absorbtion sensitizers for optical data storage media and methods for use

A process for preparing polyimide resins comprises stirring a diamine and a dianhydride in a solvent to form a slurry; heating the slurry to a temperature sufficient for the diamine and dianhydride to react wherein the temperature is below the melting point of the dianhydride, below the melting point of the diamine, or below the melting points of the dianhydride and diamine; and reacting the diamine and dianhydride to form a polyimide having sufficient molecular weight to precipitate from the solvent.

Precipitative process to prepare polyimides

A method for recovering and reusing a ring-halogenation catalyst comprises: (A) contacting an aromatic compound with chlorine or bromine in the presence of a catalyst composition, where the catalyst composition comprises at least one salt comprising a Group 4-13 metal, a lanthanide metal, or an actinide metal; and at least one organic counterion derived from an organic acid having a pKa relative to water of 0 or greater; and at least one organic sulfur compound; to form a first product mixture comprising a monochloro or a monobromo aromatic compound and a Group 4-13 metal halide, a lanthanide metal halide or an actinide metal halide; (B) separating the metal halide from the first product mixture; and (C) contacting at least a portion of the metal halide and an aromatic compound with chlorine or bromine, and at least one organic sulfur compound; to form a second product mixture comprising a monochloro or a monobromo aromatic compound and a Group 4-13 metal halide, a lanthanide metal halide or an actinide metal halide.ving a pKa relative to water of 0 or greater; and at least one organic sulfur compound.

Methods for recycling catalyst compositions for aromatic ring halogenation

A polysiloxane copolymer composition comprises: a polysiloxane unit comprising 4 to 50 siloxane units, and a polyester-polycarbonate unit consisting of 50 to 100 mole percent of arylate ester units, less than 50 mole percent aromatic carbonate units, less than 30 mole percent resorcinol carbonate units, and less than 35 mole percent bisphenol carbonate units, wherein the siloxane units are present in the polysiloxane unit in an amount of 0.2 to 10 wt % of the total weight of the polysiloxane copolymer composition, and wherein the polysiloxane copolymer composition has a 2 minute integrated heat release rate of less than or equal to 65 kilowatt-minutes per square meter (kW-min/m) and a peak heat release rate of less than 65 kilowatts per square meter (kW/m) as measured using the method of FAR F25.4, in accordance with Federal Aviation Regulation FAR 25.853 (d). A window article for an aircraft, comprising the polysiloxane copolymer composition, is also disclosed.

Polysiloxane copolymers, thermoplastic composition, and articles formed therefrom

A method of preparing a halophthalic acid is disclosed which comprises the steps of contacting in a liquid phase reaction mixture at least one halogen-substituted ortho-xylene with oxygen and acetic acid at a temperature in a range between about 120&#xb0; C. and about 220&#xb0; C. in the presence of a catalyst system yielding a product mixture comprising less than 10 percent halogen-substituted ortho-xylene starting material, a halophthalic acid product, and less than about 10,000 ppm halobenzoic acid and less than about 1000 ppm halophthalide by-products based on a total amount of halophthalic acid present in the product mixture. In addition methods for the preparation of halophthalic anhydride, and recovery of high purity acetic acid from an aqueous acetic acid stream comprising HCl, which is generated during the preparation of the halophthalic acid are also disclosed.

Method of making halophthalic acids and halophthalic anhydrides

Growing community of inventors

Niskayuna, NY, United States of America

Robert Edgar Colborn